ARQT logo Arcutis Biotherapeutics : ARQT

ARQT

Stock Data

$25.98

Change down

$0.80 (2.99%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Arcutis Biotherapeutics Inc is a biopharmaceutical firm dedicated to crafting and bringing to market treatments for skin conditions. With a leading product, ARQ-151, aimed at addressing plaque psoriasis and atopic dermatitis, the company is at the forefront of dermatological innovation. Their pipeline also includes solutions for scalp psoriasis, seborrheic dermatitis, hand eczema, vitiligo, and alopecia areata, showcasing their commitment to tackling a wide range of dermatological challenges. Founded in 2016 and based in Westlake Village, California, Arcutis is pushing the boundaries of skin health.

All Arcutis Biotherapeutics Articles

5 Articles

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.